Results 201 to 210 of about 160,408 (307)

Rectal stump management in paediatric ulcerative colitis—An international survey for the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition PORTO Inflammatory Bowel Disease group study

JPGN Reports, EarlyView.
Abstract Objective To evaluate current international clinical practice in the assessment and management of rectal stump disease activity following colectomy in paediatric ulcerative colitis (UC). Methods A web‐based survey comprising 18 questions was distributed to paediatric gastroenterologists via European Porto inflammatory bowel disease (IBD ...
Beth Gordon, Sarah Cooper, Billy Bourke, Séamus Hussey   +3 more
wiley   +1 more source

Declining rates of surgery in pediatric-onset inflammatory bowel disease: a Swedish nationwide register-based cohort study 2002-2022. [PDF]

J Crohns Colitis
Rolandsdotter H, Kristjánsson K, Everhov ÅH, Nordenvall C, Swibreg Study Group, Malmborg P, Myrelid P, Bräutigam M, Ludvigsson JF, Olén O.   +9 more
europepmc   +1 more source

The ‘Cross‐Trust’ Histopathology Multidisciplinary Team: Report of meeting outputs and impact on paediatric inflammatory bowel disease management in a UK tertiary centre

JPGN Reports, EarlyView.
Abstract Objectives To evaluate the outputs and clinical impact of a Cross‐Trust Histopathology Multidisciplinary Team (MDT) created to support diagnostic clarification and management of complex paediatric inflammatory bowel disease (IBD) cases, particularly during transition to adult services.
Valeria Dipasquale, Alenka J. Brooks, Marta Cohen, Jonathan Bury, Akshay Kapoor, Priya Narula   +5 more
wiley   +1 more source

Complementary and alternative medicine use by patients in pediatric gastroenterology clinics

JPGN Reports, EarlyView.
Abstract Objectives Use of complementary and alternative medicine (CAM) therapies among children seen in pediatric gastroenterology (GI) clinics is high. Multiple CAM therapies are effective as primary and adjuvant therapies for GI disorders and symptoms. Our study aimed to define the historical use of CAM and interest in CAM therapies in a specialized
Joshua D. Prozialeck, Lauren M. Potthoff, Bridget Whitehead, John E. Fortunato   +3 more
wiley   +1 more source

Stromal ARHGEF15 Correlates With Inflammatory EMT and Stromal-Immune Crosstalk During Inflammatory Bowel Disease-To-Colorectal Cancer Progression. [PDF]

Bioinform Biol Insights
GuoliangLi, Hao X, Chen G, Huang G, Wu Y, Jiang K, Jiang H.   +6 more
europepmc   +1 more source

Proactive therapeutic drug monitoring of infliximab leads to treatment durability in paediatric Crohn's disease: A single‐centre Australian experience

JPGN Reports, EarlyView.
Abstract Objectives To evaluate the durability and predictors of loss of response of infliximab (IFX) over 2 years in paediatric Crohn's disease (CD) utilizing a proactive therapeutic drug monitoring (TDM) strategy. Methods A retrospective, single‐centre cohort study was conducted at The Children's Hospital at Westmead (CHW), Australia, from January ...
Cher Wei Chuah, Jessica Eldredge, Annabel Magoffin, Edward Vincent O'Loughlin, Calvin Joomann Park, Juliana Puppi, Susan Siew, Michael Stormon, Kunal Thacker, Shoma Dutt   +9 more
wiley   +1 more source

Dietary Beliefs and Habits in Pediatric IBD: Insights from a Single-Center Survey. [PDF]

Nutrients
Dohos D, Kasznár E, Karoliny A, Bajzát D, Tímár ÁE, Szentannay J, Szabó A, Gombos E, Müller KE.   +8 more
europepmc   +1 more source

Outcomes of adalimumab biosimilar nonmedical switches in children and young adults with inflammatory bowel disease

JPGN Reports, EarlyView.
Abstract Objectives Adalimumab biosimilars are as safe and effective compared to the originator. Adult patients with inflammatory bowel disease (IBD) who switched to a biosimilar have comparable outcomes, but pediatric data are limited. This study evaluates clinical outcomes of children and young adults with IBD following a nonmedical, insurance‐driven
Daniel Himelstein, Megan McNicol, Mahmoud Abdel‐Rasoul, Brendan M. Boyle, Hilary K. Michel, Ross Maltz   +5 more
wiley   +1 more source

Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III study. [PDF]

Inflamm Bowel Dis
Maseng MG, Hansen SH, Grännö O, Bang C, Lund C, Huppertz-Hauss G, Perminow G, Valeur J, Bengtson MB, Opheim R, Boyar R, Frigstad SO, Aabrekk TB, Detlie TE, Kristensen VA, Strande V, Hovde Ø, Asak Ø, Franke A, Halfvarsson J, Høivik ML, Hov JR.   +21 more
europepmc   +1 more source

A joint transdisciplinary approach for paediatric inflammatory bowel disease: Integrating nursing, dietetic and psychological support

JPGN Reports, EarlyView.
Abstract Paediatric inflammatory bowel disease (pIBD) is a long‐term, immune‐mediated condition characterised by fluctuating gastrointestinal symptoms, nutritional risk and psychosocial difficulties. Although multidisciplinary team (MDT) support is considered the gold standard, there is considerable variation in how it is delivered, and it remains ...
King‐Chi Yau, Laura Tesser, Kay Crook
wiley   +1 more source